Private Label Microneedle Patch Manufacturer Low MOQ

Are private label microneedle patches regulated as cosmetics or medical devices?

By Blake Mereby · Last reviewed October 5, 2026

The regulatory classification of a microneedle patch in the United States depends on the claims made and the mechanism of action, not the delivery technology alone. This is one of the most misunderstood aspects of launching a microneedle patch brand and getting it wrong can result in FDA warning letters, import holds, or mandatory reformulation.

Dissolving cosmetic microneedle patches that make cosmetic claims — affecting the appearance of the skin rather than its structure or function — are regulated by the FDA as cosmetics under the Federal Food, Drug, and Cosmetic Act. No pre-market approval is required. The facility should be registered with the FDA (required for domestic facilities; voluntary but strongly advisable for importers under MoCRA 2022), and the product label must comply with 21 CFR Part 701. The Modernization of Cosmetics Regulation Act (MoCRA), which took effect in December 2023, added new requirements including facility registration, product listing, safety substantiation documentation, and serious adverse event reporting.

If your patch makes drug claims — "treats acne," "reduces the clinical appearance of psoriasis," "delivers minoxidil for hair growth" — the product is regulated as an OTC drug or prescription drug, depending on the active. This requires an approved New Drug Application (NDA) or conformance with an FDA OTC monograph. This is an entirely different commercial and regulatory pathway with significantly higher barriers.

Solid metal microneedles (non-dissolving) used as a skin-conditioning tool to enhance penetration of a separate topical product occupy a gray area. The FDA has generally classified these as cosmetic devices when sold with cosmetic use claims, but enforcement has been inconsistent. If you are building a roller or stamp-style metal microneedle product, consult a regulatory attorney before launch.

In the European Union, dissolving cosmetic microneedle patches fall under the EU Cosmetics Regulation (EC) 1223/2009. Mandatory requirements include a Cosmetic Product Safety Report (CPSR), a Responsible Person in the EU, CPNP notification, and compliance with Annex III–VI restricted and prohibited substances lists. The EU is generally stricter than the US on certain actives (e.g., retinol concentration limits for body and face were tightened in 2023 by the SCCS).

In South Korea — a major manufacturing hub — microneedle patches sold as cosmetics fall under the K-Beauty regulatory framework governed by the Ministry of Food and Drug Safety (MFDS). Korean manufacturers are generally experienced with both MFDS and US/EU export requirements, which is one reason they dominate global supply.

The single biggest mistake indie founders make is using language in their marketing that inadvertently makes a drug claim — phrases like "heals," "repairs damaged skin," "clinically treats" — without realizing the regulatory consequence. Work with a regulatory consultant to review all claims before launch. AJ Cosmo Labs can connect you with regulatory consultants as well as manufacturers through the platform, so you can get both sides of your launch infrastructure sorted in one place.

Ingredients in this answer: Retinol

Read the full guide on Private Label Microneedle Patch Manufacturer Low MOQ →

More about Private Label Microneedle Patch Manufacturer Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app